Topic
Diabetes management
About: Diabetes management is a research topic. Over the lifetime, 6060 publications have been published within this topic receiving 164670 citations.
Papers published on a yearly basis
Papers
More filters
Patent•
22 Nov 2006
TL;DR: In this paper, an automated healthcare communication system that facilitates communications between healthcare providers and patients and provides timely data to providers to help patients self-manage their diabetes is presented to help them learn about the disease and develop appropriate behaviors that improve their health.
Abstract: An automated healthcare communication system (10) that facilitates communications between healthcare providers (16) and patients (14) and provides timely data to providers to help patients self-manage their diabetes. Messages are presented to patients (14) at pre-selected times to help them learn about the disease and develop appropriate behaviors that improve their health and to prompt them for data or for answers to specific questions or surveys. The system applies advanced speech recognition technology (40) to make the system easy for patients (14) to use and understand via a telephone network (18). Data collected from the patient is presented in real-time to healthcare providers (16) so the patients' progress can be monitored and treatment plans adjusted accordingly.
95 citations
TL;DR: Improved blood glucose control during the hospitalization of patients with known hyperglycemia is associated with reduced morbidity, reduced hospital length of stay, and cost savings.
95 citations
TL;DR: There is variation in the availability and quality of pharmacological, chemical and clinical studies to explain traditional use of medicinal plants used to manage diabetes in Central America and of the current scientific knowledge that might explain their traditional use.
95 citations
TL;DR: The 'pros and cons' of the strategy to use these compounds in diabetes management are critically reexamined and suggestions are made that might facilitate progress of GKA R&D that could still result in a novel antidiabetic medicine.
95 citations
TL;DR: Ginseng modestly yet significantly improved fasting blood glucose in people with and without diabetes, and larger and longer randomized controlled trials using standardized ginseng preparations are warranted to address the uncertainty in effect estimates.
Abstract: Importance Despite the widespread use of ginseng in the management of diabetes, supporting evidence of its anti-hyperglycemic efficacy is limited, necessitating the need for evidence-based recommendations for the potential inclusion of ginseng in diabetes management. Objective To elucidate the effect of ginseng on glycemic control in a systematic review and meta-analysis of randomized controlled trials in people with and without diabetes. Data sources MEDLINE, EMBASE, CINAHL and the Cochrane Library (through July 3, 2013). Study selection Randomized controlled trials ≥30 days assessing the glycemic effects of ginseng in people with and without diabetes. Data extraction Relevant data were extracted by 2 independent reviewers. Discrepancies were resolved by consensus. The Heyland Methodological Quality Score and the Cochrane risk of bias tool were used to assess study quality and risk of bias respectively. Data synthesis Sixteen trials were included, in which 16 fasting blood glucose (n = 770), 10 fasting plasma insulin (n = 349), 9 glycated hemoglobin (n = 264), and 7 homeostasis model assessment of insulin resistance (n = 305) comparisons were reported. Ginseng significantly reduced fasting blood glucose compared to control (MD = −0.31 mmol/L [95% CI: −0.59 to −0.03], P = 0.03). Although there was no significant effect on fasting plasma insulin, glycated hemoglobin, or homeostasis model assessment of insulin resistance, a priori subgroup analyses did show significant reductions in glycated hemoglobin in parallel compared to crossover trials (MD = 0.22% [95%CI: 0.06 to 0.37], P = 0.01). Limitations Most trials were of short duration (67% trials<12wks), and included participants with a relatively good glycemic control (median HbA1c non-diabetes = 5.4% [2 trials]; median HbA1c diabetes = 7.1% [7 trials]). Conclusions Ginseng modestly yet significantly improved fasting blood glucose in people with and without diabetes. In order to address the uncertainty in our effect estimates and provide better assessments of ginseng's anti-diabetic efficacy, larger and longer randomized controlled trials using standardized ginseng preparations are warranted. Trial Registration ClinicalTrials.gov NCT01841229
95 citations